Clinical Trials in France / NCT06701513
Recruiting
Observational
A Real-world Study to Evaluate the Effectiveness of Deucravacitinib in Adults With Plaque Psoriasis in France (RePhlect)
NCT06701513 · tracked via the Priya Life Science France tracker
Condition(s) studied
Psoriasis
Investigational drug(s) / intervention(s)
Deucravacitinib: As prescribed by treating clinician
Study summary
The purpose of this study is to assess the real-world effectiveness of deucravacitinib treatment in adults diagnosed with moderate-to-severe plaque psoriasis
Eligibility
Inclusion Criteria:
* ≥18 years of age
* Physician-reported diagnosis of moderate to severe plaque psoriasis
* Be newly initiating deucravacitinib
* Do not object to participate
Exclusion Criteria:
* Currently participating in or planning to participate in an interventional clinical trial
* Previous treatment experience with deucravacitinib, including patients who received deucravacitinib as part of a blinded, randomized trial
Primary outcome measure(s)
- Physician's Global Assessment (PGA) 0/1 response — Baseline and at months 4, 12, 18 (optional), and 24
- Dermatology Life Quality Index (DLQI) 0/1 response — Baseline and at months 4, 12, 18 (optional), and 24
- Time from date of treatment initiation to date of discontinuation — Up to 24 months
Trial sites (48)
| Facility | City | Region | Status |
|---|---|---|---|
| Chu Amiens Picardie - Site Sud | Amiens | France | Recruiting |
| Cabinet Médical Elisabeth Lion | Angers | France | Recruiting |
| Ch Victor Dupouy | Argenteuil | France | Recruiting |
| Local Institution - 089 | Argenteuil | France | Completed |
| CH ARRAS | Arras | France | Recruiting |
| Cabinet Dermatologie | Bordeaux | France | Recruiting |
| Cabinet Dermatologie | Bordeaux | France | Recruiting |
| Centre Hospitalier William Morey - Hématologie | Chalon-sur-Saône | France | Recruiting |
| Local Institution - 053 | Clermont-Ferrand | France | Completed |
| CHU Dijon | Dijon | France | Recruiting |
| Local Institution - 077 | Dijon | France | Not Yet Recruiting |
| CHU Grenoble Alps, Service de Dermatologie | La Tronche | France | Recruiting |
| Local Institution - 014 | Le Mans | France | Not Yet Recruiting |
| CH Emile Roux | Le Puy-en-Velay | France | Recruiting |
| Centre Hospitalier Lens | Lens | France | Recruiting |
| Centre de santé Filieris | Marcq-en-Barœul | France | Recruiting |
| Hopital Saint Eloi | Montpellier | France | Recruiting |
| Tagast 41 | Nice | France | Recruiting |
| Ch Georges Renon | Niort | France | Recruiting |
| Ch Georges Renon | Niort | France | Recruiting |
| Hopital Caremeau | Nîmes | France | Recruiting |
| Cabinet de dermatologie | Paris | France | Recruiting |
| Local Institution - 086 | Paris | France | Completed |
| Hôpital Privé Francheville | Périgueux | France | Recruiting |
| Centre Hospitalier de Roubaix | Roubaix | France | Recruiting |
| Centre Hospitalier de Roubaix | Roubaix | France | Recruiting |
| Local Institution - 031 | Rouen | France | Completed |
| Local Institution - 065 | Saint-Germain-en-Laye | France | Not Yet Recruiting |
| Hia Begin | Saint-Mandé | France | Recruiting |
| Centre Dermatologique | Saint-Maur-des-Fossés | France | Recruiting |
| Hia Sainte Anne | Toulon | France | Recruiting |
| Hia Sainte Anne | Toulon | France | Recruiting |
| Hopital Larrey | Toulouse | France | Recruiting |
| Hopital Larrey | Toulouse | France | Recruiting |
| Hopital Larrey | Toulouse | France | Recruiting |
| Hopitaux de Brabois | Vandœuvre-lès-Nancy | France | Recruiting |
| Hopitaux de Brabois | Vandœuvre-lès-Nancy | France | Recruiting |
| Médipôle Hôpital Mutualiste | Villeurbanne | France | Recruiting |
| Médipôle Hôpital Mutualiste | Villeurbanne | France | Recruiting |
| Cabinet Medical | La Chaux-de-Fonds | Switzerland | Recruiting |
+ 8 more sites — see the full list on the official registry below.
More Bristol-Myers Squibb trials in France
A Study of Subcutaneous Nivolumab Versus Intravenous Nivolumab in Participants With Previously Treated Clear Cell Renal Cell Carcinoma That is Advanced or Has Spread
Active, not recruiting
Other trials for the same condition
Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?
Recruiting
A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
Active, not recruiting
A Study to Evaluate the Safety of Remsima® SC in the Treatment of RA, AS, PsA and Ps
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06701513 on ClinicalTrials.gov ↗ ← All trials in France